CVS Health (NYSE:CVS – Get Rating) had its price objective decreased by Morgan Stanley from $124.00 to $119.00 in a report released on Wednesday, Marketbeat.com reports. The firm currently has an “overweight” rating on the pharmacy operator’s stock. Morgan Stanley’s target price indicates a potential upside of 18.93% from the company’s previous close.
CVS has been the subject of several other reports. Tigress Financial lifted their price objective on CVS Health from $125.00 to $130.00 in a research report on Wednesday, August 17th. UBS Group boosted their target price on CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a research report on Thursday, August 4th. Mizuho boosted their target price on CVS Health from $115.00 to $120.00 and gave the company a “buy” rating in a research report on Monday, August 15th. Deutsche Bank Aktiengesellschaft boosted their target price on CVS Health from $113.00 to $120.00 in a research report on Thursday, August 4th. Finally, Raymond James decreased their target price on CVS Health from $120.00 to $115.00 in a research report on Sunday, November 6th. Four analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $118.00.
CVS Health Stock Performance
CVS stock opened at $100.06 on Wednesday. The stock has a 50-day moving average price of $96.19 and a 200-day moving average price of $96.79. CVS Health has a 1-year low of $86.28 and a 1-year high of $111.25. The company has a current ratio of 0.94, a quick ratio of 0.69 and a debt-to-equity ratio of 0.72. The firm has a market cap of $131.48 billion, a PE ratio of 42.58, a price-to-earnings-growth ratio of 1.57 and a beta of 0.69.
Hedge Funds Weigh In On CVS Health
About CVS Health
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.